BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8322810)

  • 1. Hematologic abnormalities in children with Down syndrome.
    Roizen NJ; Amarose AP
    Am J Med Genet; 1993 Jun; 46(5):510-2. PubMed ID: 8322810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trace elements and transport proteins in serum of children with Down syndrome and of healthy siblings living in the same environment.
    Annerén G; Gebre-Medhin M
    Hum Nutr Clin Nutr; 1987 Jul; 41(4):291-9. PubMed ID: 2442124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrinsic abnormalities of lymphocyte counts in children with down syndrome.
    de Hingh YC; van der Vossen PW; Gemen EF; Mulder AB; Hop WC; Brus F; de Vries E
    J Pediatr; 2005 Dec; 147(6):744-7. PubMed ID: 16356423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obstructive sleep apnoea in children with Down syndrome.
    Ng DK; Hui HN; Chan CH; Kwok KL; Chow PY; Cheung JM; Leung SY
    Singapore Med J; 2006 Sep; 47(9):774-9. PubMed ID: 16924359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma carnitine levels in children with Down syndrome.
    Seven M; Cengiz M; Tüzgen S; Iscan MY
    Am J Hum Biol; 2001; 13(6):721-5. PubMed ID: 11748810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma nerve growth factor (NGF) and inflammatory cytokines (IL-6 and MCP-1) in young and adult subjects with Down syndrome: an interesting pathway.
    Corsi MM; Dogliotti G; Pedroni F; Palazzi E; Magni P; Chiappelli M; Licastro F
    Neuro Endocrinol Lett; 2006 Dec; 27(6):773-8. PubMed ID: 17187019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-dependent decreases in mitogen-stimulation level and RNA content in peripheral blood mononuclear cells of Down syndrome patients.
    Hamurcu Z; Demirtas H; Patiroglu T; Kumandas S; Imamoglu N; Ozkul Y; Donmez-Altuntas H
    Cytometry B Clin Cytom; 2007 Jan; 72(1):43-8. PubMed ID: 17041944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholelithiasis in Down syndrome.
    Chen MH; Chen SJ
    Acta Paediatr Taiwan; 2004; 45(5):269-71. PubMed ID: 15868808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palatal and dental arch morphology in Down syndrome.
    Skrinjarić T; Glavina D; Jukić J
    Coll Antropol; 2004 Dec; 28(2):841-7. PubMed ID: 15666619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related changes in humoral and cell-mediated immunity in Down syndrome children living at home.
    Lockitch G; Singh VK; Puterman ML; Godolphin WJ; Sheps S; Tingle AJ; Wong F; Quigley G
    Pediatr Res; 1987 Nov; 22(5):536-40. PubMed ID: 2960948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased amyloid beta protein levels in children and adolescents with Down syndrome.
    Mehta PD; Capone G; Jewell A; Freedland RL
    J Neurol Sci; 2007 Mar; 254(1-2):22-7. PubMed ID: 17275850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periodontal conditions in individuals with Down's syndrome.
    Bagić I; Verzak Z; Cuković-Cavka S; Brkić H; Susić M
    Coll Antropol; 2003; 27 Suppl 2():75-82. PubMed ID: 12971174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial alterations and tendency to apoptosis in peripheral blood cells from children with Down syndrome.
    Roat E; Prada N; Ferraresi R; Giovenzana C; Nasi M; Troiano L; Pinti M; Nemes E; Lugli E; Biagioni O; Mariotti M; Ciacci L; Consolo U; Balli F; Cossarizza A
    FEBS Lett; 2007 Feb; 581(3):521-5. PubMed ID: 17250829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased neonatal thyrotropin in Down syndrome.
    Myrelid A; Jonsson B; Guthenberg C; von Döbeln U; Annerén G; Gustafsson J
    Acta Paediatr; 2009 Jun; 98(6):1010-3. PubMed ID: 19239410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple evidence for an early age pro-oxidant state in Down Syndrome patients.
    Pallardó FV; Degan P; d'Ischia M; Kelly FJ; Zatterale A; Calzone R; Castello G; Fernandez-Delgado R; Dunster C; Lloret A; Manini P; Pisanti MA; Vuttariello E; Pagano G
    Biogerontology; 2006 Aug; 7(4):211-20. PubMed ID: 16612664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrocytosis in Down syndrome.
    Wachtel TJ; Pueschel SM
    Am J Ment Retard; 1991 Jan; 95(4):417-20. PubMed ID: 1825915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ontogenetic changes in serum S100B in Down syndrome patients.
    Netto CB; Portela LV; Ferreira CT; Kieling C; Matte U; Felix T; da Silveira TR; Souza DO; Gonçalves CA; Giugliani R
    Clin Biochem; 2005 May; 38(5):433-5. PubMed ID: 15820773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diminished zinc plasma concentrations and alterations in the number of lymphocyte subpopulations in Down's syndrome patients].
    Soto-Quintana M; Alvarez-Nava F; Rojas-Atencio A; Granadillo V; Fernández D; Ocando A; López E; Fulcado W
    Invest Clin; 2003 Mar; 44(1):51-60. PubMed ID: 12703183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF-I levels in prepubertal and pubertal children with Down syndrome.
    Ragusa L; Valetto MR; Proto C; Alberti A; Romano C; Rossodivita A; Corneli G; Baffoni C; Lanfranco F; Aimaretti G; Colabucci F; Ghigo E
    Minerva Endocrinol; 1998 Jun; 23(2):31-6. PubMed ID: 9844353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemoglobin concentration, hematocrit and leukocyte distribution pattern in children with Down's syndrome].
    Bartelik S
    Pediatr Pol; 1995 Jun; 70(6):467-71. PubMed ID: 8692603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.